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SUMMARY
This study assessed risk factors for respiratory syncytial virus (RSV) hospitalization and disease
severity in Wellington, New Zealand. During the southern hemisphere winter months of
2003–2005, 230 infants aged<24 months hospitalized with bronchiolitis were recruited. RSV was
identiﬁed in 141 (61%) infants. Comparison with data from all live hospital births from the same
region (2003–2005) revealed three independent risk factors for RSV hospitalization: birth
between February and July [adjusted risk ratio (aRR) 1.62, 95% conﬁdence interval (CI)
1.15–2.29], gestation<37 weeks (aRR 2.29, 95% CI 1.48–3.56) and Maori ethnicity
(aRR 3.64, 95% CI 2.27–5.85) or Paciﬁc ethnicity (aRR 3.60, 95% CI 2.14–6.06). The high
risk for Maori and Paciﬁc infants was only partially accounted for by other known risk factors.
This work highlights the importance of RSV disease in indigenous and minority populations,
and identiﬁes the need for further research to develop public health measures that can reduce
health disparities.
INTRODUCTION
Internationally, respiratory syncytial virus (RSV) is
the leading cause of lower respiratory tract disease
during infancy and is responsible for 50–80% of
hospitalizations for bronchiolitis [1]. In New Zealand
(NZ) bronchiolitis admission rates are increasing.
In 1998 the rate of bronchiolitis admissions for
infants aged <12 months was estimated at 58/1000
[2], roughly double that of North American and
European infants [3, 4]. More recently, NZ Health
Information Service public hospital discharge data
for 2003–2005 show bronchiolitis rates for infants
aged<12 months have increased to 72/1000 [5].
Major risk factors for RSV bronchiolitis hospital-
ization include: pre-term delivery, severe underlying
cardiac, respiratory or neuromuscular disease, and
immunodeﬁciency [6]. However, an audit of NZ
bronchiolitis hospitalizations revealed that increased
admission rates were unaccompanied by proportion-
ate increases in these risk factors [2, 7]. Therefore,
in order to more accurately assess risk factors for
hospitalization in NZ, we undertook a single centre,
hospital-based study of RSV bronchiolitis during
three consecutive RSV epidemic seasons (2003–2005)
in Wellington, NZ.
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METHODS
Setting and subjects
Wellington Hospital provides the city’s sole in-patient
paediatric services. Eligible cases were infants aged
<24 months in hospital Monday–Friday with com-
munity-acquired bronchiolitis during three consecu-
tive RSV epidemic seasons (June/July to October
2003–2005). A diagnosis of bronchiolitis was based
upon coryzal symptoms followed by signs of res-
piratory distress and ﬁne, inspiratory crackles on
auscultation [8]. Hospital admission guidelines in-
cluded one or more of the following: (i) respiratory
distress (e.g. tachynpnoea, chest recession), (ii) ap-
noea, (iii) inability to feed, (iv) pulse oximetry<92%
in air, (v) underlying chronic medical conditions such
as cardiopulmonary diseases, immunodeﬁciency or
neuromuscular disorders and (vi) adverse social cir-
cumstances from a lack of transport or telephone [9].
The Central Regional Ethics Committee approved
the study and written, informed consent was gained
from the infant’s parent or guardian.
Demographic and clinical data
Demographic and clinical data were collected during
hospitalization. Gender, ethnicity, gestational age,
birth weight, age and weight at admission, breast-
feeding history, tobacco smoke exposure and under-
lying chronic medical disorders were recorded by a
nurse-administered 25-item questionnaire (English or
Paciﬁc languages). Ethnicity was determined using
NZ Census data methodology that prioritizes eth-
nicity of those identifying with multiple ethnic
groups to a single ethnic category as follows: Maori>
Paciﬁc>Other>NZ European/Pakeha (Caucasian)
[10].
The severity index score took oxygen requirement
as the best single measure of illness severity in hospi-
talized infants with bronchiolitis [11]. Infants requir-
ing assisted ventilation or continuous positive airway
pressure (CPAP) were classiﬁed as severe, those re-
quiring oxygen supplementation as moderate, and
those hospitalized but not requiring oxygen as mild.
Length of hospitalization was recorded as 0–24 h=1
day, 25–48 h=2 days and so on.
The New Zealand Deprivation Index (NZDep2001)
was used as a proxy measure for socioeconomic status
and was determined from the infant’s address.
NZDep2001 used pooled 2001 census data for nine
dimensions of material and social status, including
household crowding, to measure socioeconomic
status at a neighbourhood level. A score ranging from
1 to 10 was allocated to each neighbourhood, decile
1 representing the least deprived 10% of neighbour-
hoods and decile 10 the most deprived 10% [12].
The Wellington Women’s Hospital Perinatal In-
formation Management System database allowed
comparisons to be made between subject and infant
birth populations from the same region. Gender,
month of birth, gestational age, birth weight, single-
ton pregnancy, ethnicity, tobacco smoke exposure
during pregnancy and NZDep2001 scores were ob-
tained from the database for all live hospital births in
the Wellington region for 2003–2005.
Management of cases
Infants were managed by continuous monitoring of
oxygen saturation by pulse oximetry and, if required,
supplemental oxygen maintained oxygen saturation
>92% [7]. Infants not tolerating oral ﬂuids received
intravenous ﬂuids or milk via a nasogastric tube.
CPAP and intravenous ﬂuids were administered when
infants required more than 60% inspired oxygen,
while assisted ventilation was instituted for recurrent
apnoea, increasing hypoxaemia or exhaustion. No
drugs were used routinely. Discharge followed re-
establishment of normal feeding without supplemen-
tal oxygen and absence of fever.
Sample collection and laboratory methods
Nasopharyngeal aspirates were performed routinely
on infants admitted with bronchiolitis. The Hospital’s
Diagnostic Laboratory conductedRSVantigen testing
by direct immunoﬂuorescence assay (RSV Imagen,
DakoCytomation, Cambridgeshire, UK) within 2 h
of sample collection. An aliquot from each specimen
was taken immediately to the Malaghan Institute,
where RNA was extracted and viral subtyping con-
ducted by RT–PCR and nested PCR [13].
Statistical analysis
Data were analysed using SAS version 9.1 (SAS
Institute, Cary, NC, USA) and Stata statistical soft-
ware (release 8.2, Stata Corporation, College Station,
TX, USA). Analyses of RSV incidence were conduc-
ted using Poisson regression to estimate incidence rate
ratios [14] initially with univariate analyses, then with
multiple regression analyses including variables for
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birth weight, ethnicity, gestation, NZDep2001 score
and passive tobacco smoke exposure. Analyses of
factors that aﬀected severity in RSV-positive children
were conducted using logistic regression to estimate
prevalence odds ratios [14], initially only adjusted
for year (termed ‘univariate ’), then with multiple re-
gression analyses including the key factors of interest
(ethnicity, gestation, birth weight, NZDep2001 score),
and factors that showed elevated risks in univariate
analyses. A similar approach was adopted for the
analyses of factors that aﬀected length of hospital
stay. Multicollinearity was tested for, and not found
to be a signiﬁcant problem in the multivariate model.
Therefore, all variables were retained in the ﬁnal
analyses.
RESULTS
RSV was conﬁrmed in 141 (61.3%) of 230 infants
hospitalized with bronchiolitis. Of the 141 RSV-
positive samples, 135 (95.7%) were typed as RSV
subgroup A or B. One infant had RSV subgroup B
detected during his ﬁrst admission and subgroup A
was identiﬁed 3 weeks later when he was readmitted
with a new episode of bronchiolitis. No deaths were
directly attributable to bronchiolitis. In 2003 and
2005, the epidemics were predominantly RSV subtype
A (72.5% and 80.5%, respectively). By contrast, the
2004 epidemic was predominantly subtype B (60.0%).
Analysis of risk factors for RSV hospitalization and
demographic variables
Table 1 shows the characteristics of the 141 RSV-
positive infants, compared with all live hospital births
during 2003–2005 in the Wellington region and the
associated rate ratios (RRs) for RSV bronchiolitis
hospitalization.
Subjects were compared with patients hospitalized
for bronchiolitis during 2003 and 2004 using the
departmental database. The database for 2005 was
incomplete at the time of writing. Overall, 66.5% of
eligible patients (admitted during weekdays) were
enrolled. The main reason for non-participation was
discharge from hospital before research staﬀ were
able to approach their caregivers. This occurred pre-
dominantly when infants were admitted to hospital
late in the week and were sent home over the weekend
or early Monday morning. Database review showed
non-participants (including those from weekends)
were of similar age (91.0% aged <12 months at
admission and 47.2% aged <6 months) to study
subjects (87.9% aged <12 months, 55.3% aged <6
months). Ethnic distribution (38.2% European/other,
30.3% Maori, 31.5% Paciﬁc) was also similar to
study participants (Table 1).
The median age of infants hospitalized with RSV
was 5.1 months (interquartile range 2.0–9.0). The
mean and median length of hospitalization was 5.1
days [95% conﬁdence interval (CI) 4.5–5.7] and 4.0
days (interquartile range 2.0–7.0), respectively. Fifteen
(10.6%) RSV-positive infants had a major underlying
illness (cardiac, respiratory, Down’s syndrome or
achondroplasia).
The prioritized ethnicity of RSV hospitalized in-
fants varied signiﬁcantly from the general infant
population (Table 1) with Maori and Paciﬁc children
signiﬁcantly over-represented in the hospitalized
group. Multivariate analysis identiﬁed Maori or
Paciﬁc ethnicity as an independent risk factor for
hospitalization. Infants who lived in more deprived
areas (NZDep2001 deciles 8–10) were also signiﬁ-
cantly over-represented compared with the general
infant population. Infants in more deprived areas
comprised almost half (47.5%) of all study subjects.
A total of 29% were in the lowest socioeconomic
group and had a signiﬁcant crude RR for hospital-
ization. However, when adjusted for other risk factors
this was markedly reduced and no longer signiﬁcant,
indicating that the association of lower socio-
economic status with hospitalization was in part due
to other factors controlled in the model (e.g. maternal
smoking, gestational age and ethnicity).
One third (34.0%) of RSV-positive hospitalized
infants had mothers who smoked during pregnancy,
signiﬁcantly more than the general infant population
(14.7%). Although the crude RR showed maternal
smoking during pregnancy to be signiﬁcantly associ-
ated with hospitalization, this was no longer so in the
multivariate analysis (Table 1). In this study, more
than half (54.6%) of the RSV-positive hospitalized
infants came from a household with one or more
smokers. The most recent NZ data available regard-
ing household tobacco smoke exposure is from the
1996 census, and indicate that just under one third of
households with dependant children (<15 years) have
one or more smokers [15].
The majority of RSV-positive infants (61.7%) were
born in the 6 months preceding the RSV epidemic
season (February–July, inclusive). Table 1 shows
that infants born between February and July had a
signiﬁcantly increased risk for hospitalization, even
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when adjusted for other risk factors. Most infants had
birth weights o2500 g (79.4%), with 10.2% below
the 10th gestation-adjusted weight percentile. Simi-
larly, 10.3% had an admission weight below the 10th
age-adjusted weight percentile (not shown in table).
Of hospitalized RSV-positive infants, 85.8% had
been breastfed and 45.4% were still breastfeeding
(not shown in table).
Most RSV-positive infants came from a household
in which other children lived; 67.9% shared a house
with 1–2 other children, and 13.6% with o3 other
children (not shown in table). Most infants (63.5%)
Table 1. Characteristics and multivariate analysis of 141 RSV-positive infants admitted with bronchiolitis
during 2003–2005 to Wellington Hospital, compared with all live hospital births in the Wellington region
during the same period
Study variable
Infants hospitalized
for RSV infection
General infant
population Crude rate ratios Adjusted rate ratio#
n (%) n (%) RR (95% CI) RR (95% CI)
Gender
Male 82 (58.2) 5816 (51.6) 1.30 (0.93–1.82) 1.25 (0.89–1.75)
Female 59 (41.8) 5454 (48.4) 1.00 1.00
Month of birth
February–July 87 (61.7) 5537 (49.1) 1.67 (1.19–2.34)* 1.62 (1.15–2.29)*
August–January 54 (38.3) 5733 (50.9) 1.00 1.00
Multiple birth
Yes 10 (7.1) 524 (4.6) 1.57 (0.83–2.96) 1.25 (0.62–2.54)
No 131 (92.9) 10 746 (95.4) 1.00 1.00
Mother smoking during pregnancy
Yes 48 (34.0) 1658 (14.7) 2.98 (2.11–4.20)* 1.41 (0.95–2.10)
No 92 (65.2) 9457 (83.9) 1.00 1.00
n.d. 1 (0.7) 155 (1.4)
Ethnicity (priority method) [10]
Maori 49 (34.8) 1533 (13.6) 5.00 (3.35–7.44)* 3.64 (2.27–5.85)***
Paciﬁc 37 (26.2) 1207 (10.7) 4.79 (3.12–7.35)* 3.60 (2.14–6.06)***
Other 9 (6.4) 1321 (11.7) 1.06 (0.52–2.17) 1.09 (0.52–2.25)
European (Pakeha) 46 (32.6) 7189 (63.8) 1.00 1.00
n.d. 0 (0.0) 20 (0.2)
NZDep2001 score$
1 13 (9.2) 2346 (20.8) 1.00 1.00
2 11 (7.8) 1448 (12.8) 1.37 (0.62–3.05) 1.25 (0.56–2.81)
3 11 (7.8) 1203 (10.7) 1.65 (0.74–3.67) 1.46 (0.65–3.29)
4 9 (6.4) 1041 (9.2) 1.56 (0.67–3.64) 1.19 (0.50–2.81)
5 13 (9.2) 966 (8.6) 2.43 (1.13–5.22)* 1.77 (0.80–3.93)
6 7 (5.0) 812 (7.2) 1.56 (0.62–3.89) 1.09 (0.43–2.78)
7 10 (7.1) 839 (7.4) 2.15 (0.95–4.89) 1.42 (0.61–3.31)
8 10 (7.1) 577 (5.1) 3.13 (1.38–7.10)* 1.69 (0.71–3.97)
9 16 (11.3) 591 (5.2) 4.89 (2.36–10.10)* 1.99 (0.90–4.37)
10 41 (29.1) 1370 (12.2) 5.40 (2.90–10.04)* 1.89 (0.93–3.84)
n.d. 0 (0.0) 77 (0.7)
Gestational age (weeks)
<37 weeks 32 (22.7) 1178 (10.5) 2.52 (1.70–3.71)* 2.29 (1.48–3.56)**
o37 weeks 109 (77.3) 10 092 (89.5) 1.00 1.00
Total 141 11 270
RSV, Respiratory syncytial virus ; RR, rate ratio ; CI, conﬁdence interval ; n.d., no data available.
# Multivariate rate ratio adjusted for all other variables in Table 1.
$ Proxy measure for socioeconomic deprivation, where decile 1 represents the 10% least deprived and decile 10 the 10%
most deprived of neighbourhoods.
* Pf0.05, ** Pf0.0005, *** Pf0.0001.
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lived with two adults, and 8.5% lived with just one
adult. More than half (57.6%) of RSV-positive in-
fants in this study shared their sleeping space with
one or more others. Only a small percentage (13.5%)
attended day-care, which was expected since most
RSV-positive infants were aged<6 months.
Analysis of risk factors for RSV disease severity
RSV disease severity was deﬁned by the requirement
of supplemental oxygen or assisted ventilation
(Table 2) and by length of hospital stay (Table 3).
Severe cases (n=34, 24%) were hospitalized for a
mean of 8.8 days (95% CI 7.6–10.1), moderate (n=
70, 50%) for 4.6 days (95% CI 4.0–5.2), and mild
cases (n=37, 26%) for 2.6 days (95% CI 2.0–3.1).
Infants aged <2 months at admission were more
likely to have severe disease than moderate or mild
disease; however, this was no longer signiﬁcant in
the multivariate analysis (Table 2). No signiﬁcant
correlations were identiﬁed between severe disease
and: gestational age, ascribed ethnicity (Table 2),
NZDep2001 score grouped by individual score or as
less deprived (1–5) vs. more deprived (6–10), RSV
subtype, household cigarette-smoke exposure, or
sharing a sleeping space with others (not shown in
table).
Age at admission of<2 months and multiple birth
were both identiﬁed as risk factors for hospital stay of
o5 days; however, the risk for age at admission was
no longer signiﬁcant in the multivariate analysis
(Table 3). While the odds ratio (OR) increased for
multiple births in the multivariate analysis, it was no
longer statistically signiﬁcant (Table 3). Severe cases
requiring CPAP or assisted ventilation were signiﬁ-
cantly more likely to stay in hospital for o5 days
Table 2. Risk factors for severe# (compared with moderate/mild) RSV bronchiolitis in hospitalized children
Study variable
Severe Moderate/Mild Univariate odds ratio$ Adjusted odds ratio·
n (%) n (%) OR (95% CI) OR (95% CI)
Gender
Male 18 (52.9) 64 (59.8) 0.74 (0.34–1.63) 0.79 (0.34–1.85)
Female 16 (47.1) 43 (40.2) 1.00 1.00
Month of birth
February–July 24 (70.6) 63 (58.9) 1.60 (0.69–3.71) 1.45 (0.59–3.58)
August–January 10 (29.4) 44 (41.1) 1.00 1.00
Age at admission
<2 months 13 (38.2) 22 (20.6) 2.36 (1.01–5.50)* 2.50 (0.98–6.39)
o2 months 21 (61.8) 85 (79.4) 1.00 1.00
Mother smoking during pregnancy
Yes 13 (38.2) 35 (33.0) 1.37 (0.60–3.11) 1.49 (0.58–3.80)
No 21 (61.8) 71 (67.0) 1.00 1.00
Ethnicity (priority method) [10]
Maori 12 (35.3) 37 (34.6) 1.21 (0.46–3.20) 1.34 (0.42–4.28)
Paciﬁc 9 (26.5) 28 (26.2) 1.28 (0.45–3.63) 1.42 (0.36–5.52)
Other 3 (8.8) 6 (5.6) 1.68 (0.35–8.06) 1.95 (0.37–10.29)
European (Pakeha) 10 (29.4) 36 (33.6) 1.00 1.00
Number of other children (<16 years) living in the house
o3 6 (17.6) 13 (12.3) 1.66 (0.57–4.87) 1.63 (0.52–5.11)
0–2 28 (82.4) 93 (87.7) 1.00 1.00
Gestational age (weeks)
<37 weeks 5 (14.7) 27 (25.2) 0.58 (0.20–1.67) 0.58 (0.19–1.78)
o37 weeks 29 (85.3) 80 (74.8) 1.00 1.00
RSV, Respiratory syncytial virus ; OR, odds ratio ; CI, conﬁdence interval.
# Severe=assisted ventilation or continuous positive airway pressure (CPAP) ; moderate=received supplemental oxygen;
mild=no additional oxygen needed.
$ Adjusted for year.
· Adjusted for year and all other variables listed in the table.
* Pf0.05.
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(OR adjusted for year 35.65, 95% CI 8.01–158.62),
illustrating the validity of length of hospital stay as an
alternative measure of disease severity. Again, no sig-
niﬁcant associations were identiﬁed between hospital
stay ofo5 days and: ascribed ethnicity, birth weight
centile (Table 3), NZDep2001 score grouped by
individual score or as less deprived (1–5) vs. more
deprived (6–10), RSV subtype, gestational age, house-
hold cigarette-smoke exposure, or sharing a sleeping
space with others (not shown in table).
DISCUSSION
This foremost study of RSV bronchiolitis in NZ
identiﬁed three independent risk factors for hospital-
ization: birth between February and July, gestational
age <37 weeks and Maori or Paciﬁc ethnicity. The
increased risk associated with pre-term delivery and
birth within 6 months of the annual RSV season
(presumably secondary to low protective maternal
antibody titres) is similar to observations in the
northern hemisphere [6, 16]. Multiple regression
analysis indicated the high rates in Maori and Paciﬁc
infants could only be partially accounted for by fac-
tors such as maternal smoking during pregnancy, the
deprivation status of the area in which the infant
lived, low birth weight, gender and month of birth.
Outside North America, few studies from devel-
oped countries have examined reasons for severe RSV
bronchiolitis in indigenous and disadvantaged popu-
lations [1, 17]. However, in contrast to our ﬁndings, a
recent Australian report concluded that the increased
risk of hospitalization from RSV bronchiolitis in
Indigenous infants was largely due to lower socio-
economic status-associated factors such as lower birth
weight and maternal smoking [18].
Native American and Alaskan infants also have
higher hospitalization rates for RSV bronchiolitis
Table 3. Risk factors for length of stay (o5 days vs.<5 days#) in RSV-positive children hospitalized with
bronchiolitis
Study variable
o5 days <5 days Univariate odds ratio$ Adjusted odds ratio·
n (%) n (%) OR (95% CI) OR (95% CI)
Gender
Male 40 (62.5) 42 (54.5) 1.39 (0.70–2.76) 2.25 (0.85–6.00)
Female 24 (37.5) 35 (45.5) 1.00 1.00
Multiple birth
Yes 8 (12.5) 2 (2.6) 5.35 (1.08–26.51)* 6.52 (0.89–47.96)
No 56 (87.5) 75 (97.4) 1.00 1.00
Age at admission
<2 months 22 (34.4) 38 (49.4) 2.56 (1.15–5.71)* 1.92 (0.63–5.83)
o2 months 42 (65.6) 39 (50.6) 1.00 1.00
Ethnicity (priority method) [10]
Maori 22 (34.4) 27 (35.1) 1.34 (0.58–3.09) 1.44 (0.38–5.51)
Paciﬁc 19 (29.7) 18 (23.4) 1.86 (0.76–4.58) 2.21 (0.49–10.02)
Other 5 (7.8) 4 (5.2) 1.79 (0.41–7.77) 2.43 (0.32–18.62)
European (Pakeha) 18 (28.1) 28 (36.4) 1.00 1.00
Number of other children (<16 years) living in the house
o3 12 (19.0) 7 (9.1) 2.63 (0.94–7.32) 1.09 (0.29–4.18)
0–2 51 (81.0) 70 (90.9) 1.00 1.00
Birth weight centile (gestational age-adjusted)
Low birth weight
(f10th centile)
7 (10.9) 6 (7.9) 2.78 (0.80–9.62) 2.04 (0.38–10.89)
Normal to high
(>10th centile)
57 (89.1) 70 (92.1) 1.00 1.00
RSV, Respiratory syncytial virus ; OR, odds ratio ; CI, conﬁdence interval.
# Mean length of hospitalization was 5.1 days (95% CI 4.5–5.7).
$ Adjusted for year.
· Adjusted for year and all other variables listed in the table.
* Pf0.05
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than other populations [19]. Highest rates were found
in remote rural regions of Alaska and the southwest,
while urbanized Native Americans with a higher
socioeconomic status had lower rates than the general
US infant population. These rate diﬀerences were
attributed to a combination of socioeconomic factors,
such as household crowding and access to health care
[19, 20]. A recent retrospective Californian study also
found that RSV hospitalization rates were higher
among infants of lower socioeconomic status (deﬁned
by use of Medicaid), and in rural areas with high
poverty rates [21]. Interestingly, Asian/Paciﬁc infants
and American Indian and Alaskan Native infants
using Medicaid had lower hospitalization rates than
non-hispanic white infants using Medicaid.
Our study had relatively limited information on
factors such as maternal smoking and area-based
deprivation, the latter being a crude measure of in-
dividual deprivation [22, 23]. In particular, it is prob-
able that housing conditions and overcrowding play
a role that is not fully captured by NZDep2001 scores.
It is possible that RRs for Maori and Paciﬁc infants
might have reduced towards the null value of 1.0, had
we been able to obtain more accurate information on
these risk factors and control for them more fully.
Nevertheless, these analyses suggest there may
be other untested factors, contributing to the higher
incidence of RSV hospitalization in Maori and Paciﬁc
infants. Associations between severe RSV infection
and polymorphisms of the surfactant protein gene
loci [24], interleukin (IL)-4/IL-13 genes [25], the vit-
amin D receptor [26] and many other gene loci [27, 28]
have been reported. However, no information cur-
rently exists on their prevalence in Maori and Paciﬁc
infants.
Furthermore, it is important to note that the
ethnicity to which an individual ascribes encompasses
their cultural and environmental practices as well as
their genetic heritage [29]. The contribution of each
of these factors must be considered when seeking
reasons behind the greater incidence of RSV hospital-
ization in Maori and Paciﬁc infants.
As with Alaskan Native and remote rural Indi-
genous Australian infants [30, 31], Maori and Paciﬁc
children are also known to be at greater risk than NZ
European/Pakeha children for other respiratory in-
fections and pulmonary disease [32–34]. High asthma
hospitalization rates in Maori children were pre-
viously ascribed to genetic factors, but subsequent
analyses found this was from disparities in access to
primary health care rather than underlying disease
susceptibility [35]. If hospital care was preferentially
used byMaori or Paciﬁc infants from lack of access to
primary health care, or because of hospital physician
practices, it might be expected that moderate or mild
cases would be increased for Maori or Paciﬁc infants.
However, ethnicity was not associated with disease
severity in this study, suggesting that these factors are
unlikely to be important.
Our failure to identify risk factors for more severe
RSV disease or hospitalization for o5 days in the
multivariate analysis are similar to an earlier review
of NZ infants requiring assisted ventilation for
bronchiolitis from all causes where only pre-term de-
livery was considered important [36]. This failure
could be attributed to diﬃculties in detecting signiﬁ-
cant diﬀerences within a small and highly select
population of infants with disease severe enough to
warrant hospital admission. Instead, it might be more
appropriate to compare RSV-infected infants man-
aged solely in the community with those requiring
hospitalization.
Our study reaﬃrms pre-term delivery and birth
within 6 months of the RSV epidemic season as risk
factors for hospitalization. It extends North American
ﬁndings [18, 19] of increased risk for RSV bronchio-
litis hospitalization among rural indigenous infants
by ﬁnding a similar situation exists in a NZ urban
environment. Factors contributing to this high risk
for Maori and Paciﬁc infants are probably a combi-
nation of host, environmental and behavioural fac-
tors that are worth investigating further, particularly
given the possible long-term sequelae of severe RSV
bronchiolitis [37–39]. The information gained could
also beneﬁt ethnic minorities and indigenous children
in other developed countries. Additional studies are
planned to identify interventions that may reduce
RSV hospitalization while awaiting safe and eﬀective
vaccines. This includes, for example, determining
whether deﬁciencies in micronutrients that help regu-
late innate immunity are increased in Maori and
Paciﬁc populations resident in New Zealand.
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